Skip to content
Search

Latest Stories

University of Huddersfield working on ‘Greening’ the MPharm curriculum

The Department of Pharmacy at the University of Huddersfield is working to include environmental sustainability principles into the pharmacy degree (Mpharm) curriculum to support the cause.

It has also urged other pharmacy educators to follow suit after the Royal Pharmaceutical Society (RPS) issued a declaration of climate and ecological emergency, last month.


Playing a key role in ‘greening’ the University’s MPharm curriculum, Dr Alison Astles, subject leader in pharmacy and member of the University’s Pharmaceutical Policy and Practice Research Centre said: “Mitigating climate impact will need everyone to deliver change, and our future pharmacists have to be prepared to lead that change as part of their duty to the patient.”

Dr Alison Astles Dr Alison Astles

She hopes that future pharmacists will be best placed to play their part in the fight against climate change.

She added that sustainability was already present in the University’s MPharm curriculum, it just needed refocusing through an environmental lens.

Astles said: “As part of the global effort and also particularly the NHS NetZero effort that's topical at the moment, we have decided to map our curriculum against an environmental sustainability strand to make it explicit to students, which is something we haven't done before.

“We feel that our undergraduates need to be as prepared as they can be on environmental sustainability because medicines are a huge contributor to environmental issues.”

Further, she urged other departments across the University and anyone with an interest to get in touch to update curriculums.

RPS president Claire Anderson said: As individual practitioners, and collectively as a profession, we must identify where we can make changes in our practice to reduce carbon emissions.”

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less